Leveraging The Direct-to-Patient Research Model in Rheumatoid Arthritis

July 16, 2012
Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and...
Read More

Father Knows Best

December 01, 2011
My parents aren’t world-class athletes, but in the summer of 2009 they both competed in the Senior Olympics. They were representing their home state of Wyoming, where people – much...
Read More

A Prescription for Personalizing Medicine

October 26, 2011
While a lot of the discussion about personalized medicine is focused on the future, some of the most promising possibilities for individualized care could be implemented right now, said Felix Frueh, of Medco Health Solutions. Frueh shares his perspective with The Blog in advance of the 4th annual Personalized Medicine World Conference.
Read More

23andMe Launches Its First NIH Funded Study

December 16, 2010
  By Amy Kiefer and Kim Barnholt 23andMe is excited to announce the launch of our first National Institutes of Health (NIH) funded research project. In  the fall of 2010,...
Read More

Genetic Tests Can Reduce Risks From Blood Thinner Warfarin

March 16, 2010
Today at the American College of Cardiology conference in Atlanta, researchers from the Mayo Clinic and Medco Health Solutions, Inc., presented results showing that using genetic testing to guide dosing...
Read More

FDA Updates Label for Commonly Used Blood Thinner to Include Dosing Recommendations Based on Genetics

February 04, 2010
Warfarin (Coumadin ®) is a blood thinner given to people at high risk for the formation of blood clots due to conditions such as deep vein thrombosis, heart valve disease...
Read More

Large Study Reveals Details of African American Genetic Ancestry

January 11, 2010
As shown in these ancestry paintings from 23andMe, the proportion of African DNA can vary widely for African Americans. A recent study led by Carlos Bustamante of Cornell and Sarah...
Read More

Medco to Include Genetics in Comparison of Anti-Clotting Drug Effectiveness

October 28, 2009
Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix ®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as...
Read More

New Study Shows That Genetic Information Can Improve Administration Of Commonly Used Blood Thinner

February 19, 2009
Each time a doctor writes a prescription for warfarin (Coumadin ®), a blood thinner given to about two million people each year in the United States, it’s a guessing game....
Read More

Biotech Company Applies for FDA Permission to Market Gene-Targeted Heart Failure Drug

September 25, 2008
Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to...
Read More